ACKR3 and prostate cancer: This is consistent with previous observations utilizing RNAi methods to deplete CXCR7 in prostate cancer cell lines under normal culture conditions (in the presence of androgen) which resulted in significantly reduced cell proliferation and inhibited cell cycle progression16.